Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | $218.2M | $137.5M | $53.1M | $20.5M | ($51.3M) | ($243.8M) | ($354.3M) | ($300.1M) | ($332.1M) | ($343.8M) | ($840.7M) | ($627.8M) | ($448.8M) | ($301.1M) | ($362.7M) | ($812.6M) | ($680.5M) | ($751.0M) | ($498.5M) | ($949.6M) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Edwards Lifesciences Corporation's last 12-month Net Debt is ($3,739.4M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Edwards Lifesciences Corporation's Net Debt growth was 225.6%. The average annual Net Debt growth rates for Edwards Lifesciences Corporation have been 82.5% over the past three years, 41.4% over the past five years.
Over the last year, Edwards Lifesciences Corporation's Net Debt growth was 225.6%, which is higher than industry growth of (0.4%). It indicates that Edwards Lifesciences Corporation's Net Debt growth is Bad.